SCHEMBL21276746

SCHEMBL21276746

CNc1ccc(C#Cc2ccc(OCCCN3CCOCC3)c(OC)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.51
▸ CYP2D6 P10635 2/20 0.51
▸ MAP2K1 Q02750 9/20 0.50
▸ SRC P12931 1/20 0.49
▸ QPCT Q16769 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ EGFR P00533 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ RAF1 P04049 1/20 0.47
▸ MAPK3 P27361 1/20 0.47
▸ PDGFRB P09619 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ SCN1A P35498 1/20 0.46
▸ HTR2B P41595 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18763454 0.87 AXL (0.53) TSHRCYP2D6SRCQPCTKDM4E
SCHEMBL14421397 0.83 HRH3 (0.60) TSHRCYP2D6MAP2K1SRCKDM4E
SCHEMBL21276702 0.80 UTS2R (0.55) TSHRRAF1HTR2AHTR2BHRH3
SCHEMBL524146 0.78 HRH3 (0.60) TSHRCYP2D6MAP2K1SRCKDM4E
SCHEMBL17443395 0.78 RET (0.68) RAF1PDGFRB
SCHEMBL11961176 0.78 TSHR (0.61) TSHRCYP2D6KDM4ETDP1LMNA
SCHEMBL21276750 0.77 HRH3 (0.46) TSHRCYP2D6MAP2K1KDM4ELMNA
SCHEMBL1667163 0.77 AXL (0.61) TSHRCYP2D6SRCQPCTKDM4E
SCHEMBL4572943 0.77 TSHR (0.60) TSHRCYP2D6SRCKDM4ETDP1
SCHEMBL14399501 0.76 TSHR (0.61) TSHRCYP2D6QPCTKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169671-B1 1-(5-(TERT.-BUTYL)ISOXAZOL-3-YL)-3-(4-((PHENYL)ETHYNYL)PHENYL)UREA DERIVATIVES AND RELATED COMPOUNDS AS FLT3 INHIBITORS FOR TREATING CANCER SUNSHINE LAKE PHARMA CO LTD (CN) 2019-08-21 — — EP disclosed
Send feedback